The Handoff: The Week in Neurology News

The Handoff is a weekly roundup of neurology news covering various developments in subspecialties, as well as pharmaceutical and association and society news. Keep your finger on the pulse of neurology with The Handoff.

– Impax Laboratories issued a voluntary recall of a single lot of lamotrigine due to 100 mg blister packs being packaged in 200 mg containers. The lot was distributed to wholesalers and retail pharmacies from June through August. 

– Gene Wilder’s death from “complications of Alzheimer’s” may serve as the stigma breakthrough the neurodegenerative disease desperately needs in order to raise awareness.

– Child neurologists and neurobehavioral specialists are fighting an uphill battle against dwindling staff and dissatisfaction with compensation and benefits. 

– A report from the CDC suggests that illegal fentanyl is behind a near 175% increase in opioid-related deaths in 1 year in some “high-burden” states.

– A quarrel between Georgetown researchers and the Micheal J. Fox Foundation may put a pivotal Parkinson’s disease clinical trial on hold for another year. 

– The US FDA is calling for black box warnings to be added to opioid analgesics, opioid cough products, and benzodiazepines to increase awareness of risk of death with combined use. 

– Memorial Hermann Texas Medical Center was granted nearly $7 million to expand its study of the Mobile Stroke Unit program across the US. 

– A review published in Mayo Clinic Proceedings found that complimentary health approaches — such as yoga, tai chi, and acupuncture — are effective in managing pain conditions. 

– With children across the US headed back to school — and school sports — this week, Mayo Clinic offers up some insight on the utility of concussion screenings and why it’s important to develop a baseline for young athletes. Watch the interview with sports medicine specialist Dr Jennifer Maynard below.